Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy.
Horiguchi H, Kadomatsu T, Yamashita T, Yumoto S, Horino T, Sato M, Terada K, Miyata K, Ichigozaki Y, Kimura T, Fukushima S, Moroishi T, Oike Y.
Horiguchi H, et al.
Cancer Gene Ther. 2024 Mar 11. doi: 10.1038/s41417-024-00757-9. Online ahead of print.
Cancer Gene Ther. 2024.
PMID: 38467764